Segmentation by type of irradiation isolates three core technologies: gamma‑ray, electron‑beam (e‑beam), and X‑ray, each with distinct operational and economic attributes. Gamma‑ray services, driven by Cobalt‑60 sources, dominate the market (approximately 55 %) due to deep penetration capability, enabling bulk processing of dense medical devices and large‑volume pharmaceuticals. E‑beam systems, accounting for about 30 %, offer rapid dose delivery and on‑site installation, which reduces logistics costs and enhances traceability for high‑value, temperature‑sensitive products. X‑ray irradiation, contributing roughly 15 %, provides a photon‑based alternative with comparable penetration to gamma but without radioactive source handling, appealing to facilities with stringent safety or waste‑disposal constraints. The relative share of each type reflects capital expenditure, throughput requirements, and regulatory acceptance, collectively defining the market’s technology mix and influencing service pricing structures.